Our latest publication in Cellular and Molecular Life Sciences: we identified upstream ORFs-derived #peptide as tumor-associated antigens! #immunotherapy #massSpectrometry Great work from our lab member Annika Nel in great collaboration with Uniklinik Münster link.springer.com/article/10.100…

New #article reporting on our #tcell activator against #COVID19 EN: gesundheitsindustrie-bw.de/en/article/new… DE: gesundheitsindustrie-bw.de/fachbeitrag/ak…

We are looking for new colleagues in different positions: - Lab manager :medizin.uni-tuebingen.de/de/karriere/jo… - Technical assistant: medizin.uni-tuebingen.de/de/karriere/jo… - Secretary: medizin.uni-tuebingen.de/de/karriere/jo…

Latest german report on our #SARSCoV2 #vaccine, CoVac-1, as possible #Booster and protection for immunodeficient #patients heise.de/hintergrund/Co…

Save the date! Join the #livestream of next weeks @Sectio_live episode of our 2 members Juliane Walz & Ulrich Lauer on #immunotherapy in #cancer. It is part of one of four CIVIS - Europe's Civic University Alliance summer schools at the Faculty of Medicine Tuebingen 2022. 📅21 June 🕛2:30pm CEST ℹ️ bit.ly/39lnnlo

We are looking for a new study nurse. Interested? Find out more details following this link medizin.uni-tuebingen.de/de/karriere/jo…

Interesting paper by Kuraoka et al. in Science Immunology on memory B-cell reactivation by repeated immunizations and the importance of boost #vaccine localization. science.org/doi/10.1126/sc…

Short #Article reporting on our CoVaC-1 #COVID19 peptide #vaccine published as AACR meeting highlight in @VBCancerCare valuebasedcancer.com/issues/2022/ju…

It was great fun to do this podcast on #cancer #vaccines @MT_Onkologie

Interested to work with us as study nurse, technical assistant or research secretary? Check out our open positions: medizin.uni-tuebingen.de/de/karriere/jo… medizin.uni-tuebingen.de/de/karriere/jo… medizin.uni-tuebingen.de/de/karriere/jo…

On Wednesday we dressed up for our annual #whiteparty with Peptide-based Immunotherapy. What a night🥳

We are looking for a new #research secretary. Join our great team and comfortable working environment, Translational Immunology. For more details check out the following link medizin.uni-tuebingen.de/de/karriere/jo…

An oncogenic fusion protein as target for novel #immunotherapies of cancer. We are so excited to share our study, which identified the oncogenic fusion protein DNAJB1-PRKACA as source of #neoantigens for peptide-based immunotherapy in #FLHCC! nature.com/articles/s4146…

In a new study, researchers evaluate immune responses of several #SARSCoV2 vaccines in people, showing that while boosters improve antibody responses, they do not do so as robustly for #Tcells. yacine.maringer Peptide-based Immunotherapy Universität Tübingen 📄: scim.ag/nD

We are very excited to share our work published in Science Immunology showing that different #vaccination regimens induce broad and long-lasting spike-specific CD4+ and CD8+ #Tcell immunity that is not further enhanced by booster vaccination: science.org/doi/10.1126/sc…

Enjoying the #conference as a #team Visualizing and Targeting Cancer Stress #iFIT2023 #cancer #Immunotherapy

Interesting paper by Wang et al. in nature analyzing the circadian rhythm of DCs in mice, and its potential impact on #Cancer #Immunotherapy. nature.com/articles/s4158…

Ashish Goyal, Jens Bauer und Joschka Hey erhalten den diesjährigen #WaltraudLewenzPreis für ihre Arbeit über die Identifizierung von Neoantigenen, die von neu aktivierten Transkripten bei epigenetischen Therapien kodiert werden. Herzlichen Glückwunsch! 👏 VomLaborInDiePraxis

Happy to announce that Jens Bauer from our lab together with Ashish Goyal and Joschka Hey were awarded the #WaltraudLewenzPreis 2023 DKFZ for their work on "DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts".